Please login to the form below

Not currently logged in
Email:
Password:

Jeffrey Wilks leaves eBay for inVentiv Health

He joins pharma services group as first president of advertising

inventiv-jeffrey-wilksThe pharma services group inVentiv Health has named eBay's Jeffrey Wilks as its first president of advertising.

Wilks, who was head of client services for eBay's marketing divisions, steps into a newly created role where he will support inVentiv's customers to make use of digital expertise from inVentiv's many healthcare-focused marketing agencies.

These agencies include GSW, Palio+Ignite, Navicor, JSA, inVentiv Health Communications (Europe), and Addison Whitney.

Mike Griffith, president of inVentiv commericial, said: "[Wilks] will infuse insights and operational excellence into our existing creative offerings and help each of our agencies become the preferred provider of imaginative, tech-savvy, and globally customised advertising solutions."

Wilks has vast experience in developing customer relationships in a consumer setting working for major brands such as IBM, Dell Computers, Delta Airlines, MasterCard, USA Today and Johnson & Johnson.

In his most recent role at online shopping market eBay he led a team that tailored technology-based marketing solutions for brands such as Toys 'R' Us, Wells Fargo and Sony.

Wilks spoke of his digital priorities at inVentiv: "The mobile health marketplace is racing to match the swift proliferation of on-the-go health apps, while traditional advertising is rapidly shifting to a content marketing approach.

“I look forward to advancing our capabilities, and the data-driven insights that guide them, across inVentiv's agencies to help our clients achieve their goals."

10th November 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...